BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

547 related articles for article (PubMed ID: 31932947)

  • 1. [Cutaneous lymphomas : Clinical presentation - diagnosis - treatment].
    Wobser M; Goebeler M
    Pathologe; 2020 Feb; 41(1):79-94. PubMed ID: 31932947
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Cutaneous lymphomas : Clinical presentation - diagnosis - treatment].
    Wobser M; Goebeler M
    Hautarzt; 2019 Oct; 70(10):815-830. PubMed ID: 31511903
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Epitheliotropic lymphomas: better identification for improved treatment].
    Bagot M
    Bull Acad Natl Med; 2010 Oct; 194(7):1365-72. PubMed ID: 22043631
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Diagnostics of primary cutaneous lymphomas].
    Felcht M; Hillen U; Klemke CD
    Hautarzt; 2017 Sep; 68(9):696-701. PubMed ID: 28779267
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Primary cutaneous T-cell lymphomas other than mycosis fungoides and Sézary syndrome. Part II: Prognosis and management.
    Oh Y; Stoll JR; Moskowitz A; Pulitzer M; Horwitz S; Myskowski P; Noor SJ
    J Am Acad Dermatol; 2021 Nov; 85(5):1093-1106. PubMed ID: 33945836
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Therapy of cutaneous lymphoma--current practice and future developments.
    Dummer R; Kempf W; Hess Schmid M; Häffner A; Burg G
    Onkologie; 2003 Aug; 26(4):366-72. PubMed ID: 12972705
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Primary cutaneous T-cell lymphomas other than mycosis fungoides and Sézary syndrome. Part I: Clinical and histologic features and diagnosis.
    Stoll JR; Willner J; Oh Y; Pulitzer M; Moskowitz A; Horwitz S; Myskowski P; Noor SJ
    J Am Acad Dermatol; 2021 Nov; 85(5):1073-1090. PubMed ID: 33940098
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical Practice Guidelines for Cutaneous Lymphomas.
    Sutton AM; Hurley MY
    Mo Med; 2015; 112(4):292-5. PubMed ID: 26455060
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnosis and Management of Cutaneous Lymphomas Including Cutaneous T-cell Lymphoma.
    Zic JA
    Med Clin North Am; 2021 Jul; 105(4):737-755. PubMed ID: 34059248
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cutaneous T cell lymphoma-mycosis fungoides and Sezary syndrome: an update.
    Parker SR; Bethaney JV
    G Ital Dermatol Venereol; 2009 Aug; 144(4):467-85. PubMed ID: 19755952
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Current therapeutic options in Mycosis fungoides and Sézary syndrome].
    Albrecht JD; Nicolay JP
    Hautarzt; 2022 Jan; 73(1):75-85. PubMed ID: 34988613
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cutaneous T-cell lymphoma-Focus on some problems, and some solutions.
    Beltraminelli H
    Hematol Oncol; 2023 Jun; 41 Suppl 1():20-24. PubMed ID: 37294972
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cutaneous Lymphomas -Part II: Other Cutaneous Lymphomas.
    Pujol RM; Gallardo F
    Actas Dermosifiliogr (Engl Ed); 2021 Jan; 112(1):24-31. PubMed ID: 33045210
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cutaneous lymphomas-An update 2019.
    Kempf W; Zimmermann AK; Mitteldorf C
    Hematol Oncol; 2019 Jun; 37 Suppl 1():43-47. PubMed ID: 31187534
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Joint British Association of Dermatologists and U.K. Cutaneous Lymphoma Group guidelines for the management of primary cutaneous T-cell lymphomas.
    Whittaker SJ; Marsden JR; Spittle M; Russell Jones R; ;
    Br J Dermatol; 2003 Dec; 149(6):1095-1107. PubMed ID: 14696593
    [No Abstract]   [Full Text] [Related]  

  • 16. Mycosis fungoides and Sézary syndrome: focus on the current treatment scenario.
    Sanches JA; Cury-Martins J; Abreu RM; Miyashiro D; Pereira J
    An Bras Dermatol; 2021; 96(4):458-471. PubMed ID: 34053802
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mycosis fungoides and Sézary syndrome - Review and outlook.
    Latzka J; Trautinger F
    J Dtsch Dermatol Ges; 2023 Apr; 21(4):386-391. PubMed ID: 36971307
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lymphoma-associated hemophagocytic syndrome (LAHS) in advanced-stage mycosis fungoides/Sézary syndrome cutaneous T-cell lymphoma.
    Blom A; Beylot-Barry M; D'Incan M; Laroche L
    J Am Acad Dermatol; 2011 Aug; 65(2):404-410. PubMed ID: 21550694
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mycosis fungoides and Sézary syndrome: Australian clinical practice statement.
    Bhabha FK; McCormack C; Wells J; Campbell BA; Newland K; Lade S; Buelens O; Joske D; Shortt J; Mapp S; Radeski D; Hertzberg M; Khot A; Van Der Weyden C; Khoo C; Hawkes E; Prince HM
    Australas J Dermatol; 2021 Feb; 62(1):e8-e18. PubMed ID: 33368169
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Primary cutaneous B-cell lymphomas - clinicopathological, prognostic and therapeutic characterisation of 54 cases according to the WHO-EORTC classification and the ISCL/EORTC TNM classification system for primary cutaneous lymphomas other than mycosis fungoides and Sezary syndrome.
    Golling P; Cozzio A; Dummer R; French L; Kempf W
    Leuk Lymphoma; 2008 Jun; 49(6):1094-103. PubMed ID: 18569636
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.